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Abstract
Background: The promotion of health equity, the absence of avoidable and unfair differences in health outcomes, is a
global imperative. Systematic reviews are an important source of evidence for health decision-makers, but have been
found to lack assessments of the intervention effects on health equity. The Preferred Reporting Items for Systematic
Reviews and Meta-Analysis (PRISMA) is a 27 item checklist intended to improve transparency and reporting of systematic
reviews. We developed an equity extension for PRISMA (PRISMA-E 2012) to help systematic reviewers identify, extract,
and synthesise evidence on equity in systematic reviews.
Methods and findings: In this explanation and elaboration paper we provide the rationale for each extension item.
These items are additions or modifications to the existing PRISMA Statement items, in order to incorporate a focus on
equity. An example of good reporting is provided for each item as well as the original PRISMA item.
Conclusions: This explanation and elaboration document is intended to accompany the PRISMA-E 2012 Statement and
the PRISMA Statement to improve understanding of the reporting guideline for users. The PRISMA-E 2012 reporting
guideline is intended to improve transparency and completeness of reporting of equity-focused systematic reviews.
Improved reporting can lead to better judgement of applicability by policy makers which may result in more appropriate
policies and programs and may contribute to reductions in health inequities.
To encourage wide dissemination of this article it is accessible on the International Journal for Equity in Health, Journal of
Clinical Epidemiology, and Journal of Development Effectiveness web sites.
Introduction
Promoting health equity and reducing avoidable
health inequalities is a global imperative, endorsed by
the Rio Summit in Brazil in 2011, the Pan American
Health Organization, and the World Health Organization
[1–3]. Health inequalities are differences in health out-
comes across individuals in a population or between dif-
ferent population groups whereas health inequities are
inequalities which are avoidable and unfair [4, 5]. In-
equities are not only due to poverty, but may also be
due to unfair differences in health across other char-
acteristics such as sex/gender, geography, and
ethnicity [6]. The concept of health equity also sug-
gests that groups of people should not be prevented
from achieving health due to factors such as discrim-
ination or inadequate access. In this reporting guide-
line, we focus on unfair inequalities in health
outcomes and therefore use the term ‘equity’.
Systematic reviews are recognized as an important
source of rigorously and transparently synthesized in-
formation by health decision-makers [2, 7–9]. Health
decision makers have described lack of evidence on
equity as a barrier to using systematic reviews and
guidelines [5, 10], and arguably, primary studies
themselves. However, a 2010 systematic review found
that there is a lack of detail in reporting of certain
aspects important to health equity including popula-
tion characteristics, assessment of credibility of sub-
group analyses, and judgement about the applicability
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of the findings to other settings with fewer than half
of the included reviews reporting on socio-demographic
characteristics (such as age, sex, place of residence, ethni-
city) of the study populations [11]. These are important
factors to consider for health equity and the lack of
reporting of these elements demonstrates the need to
improve reporting of equity in systematic reviews,
and to increase the overall investment in systematic
reviews that can provide a clear emphasis on consid-
erations of equity.
Reporting guidelines have been shown to improve
reporting of different study designs [12, 13]. The Pre-
ferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) is a 27 item checklist to en-
sure complete and transparent reporting of the methods
used in systematic reviews [14]. However, the original
PRISMA Statement did not include items specific for
reporting on considerations of equity. Equity consider-
ations include the definition of disadvantaged popula-
tions, methods to include equity considerations in
analyses, and applicability of the evidence to other set-
tings or populations. We developed an equity extension
of the PRISMA Statement, called PRISMA-E 2012 to re-
spond to these needs [15]. As of July 8, 2015, the
PRISMA-E 2012 reporting guideline has been viewed al-
most 16,000 times, downloaded 2661 times, cited 50
times (Scopus), and shared 109 times using Twitter (99
tweets by 70 users according to Altmetrics). It is also
cited as a reference for the World Health Organization
Handbook on Guideline Development, the Oxford Text-
book of Public Health, the Public Health Agency of
Canada guidance, the Canadian Institutes of Health
Research instructions for applicants and the Journal of
the Society for Social Work and Research. The Spanish
version of PRISMA-E 2012, published in July 2013, has
been downloaded 477 times as of November 17, 2014
(Scielo) and has received 1474 visits on the Journal’s
website [16].
To further facilitate and promote the use of the guide-
line of equity issues in systematic review (PRISMA-E
2012), we developed this explanation and elaboration to
describe each of the items and provide examples from
existing reviews to demonstrate good reporting.
Scope of PRISMA-E 2012
The PRISMA-E 2012 checklist was developed to im-
prove transparency and completeness of reporting of
systematic reviews of intervention studies with a focus
on health equity. We define systematic reviews of
intervention studies with a major focus on health
equity as those designed to:
1) Assess effects of interventions targeted at
disadvantaged or at-risk populations
(e.g., school feeding for disadvantaged
children [17]). These may not include equity
outcomes but by targeting disadvantaged
populations will reduce inequities.
2) Assess effects of interventions aimed at
reducing social gradients across populations
or among subgroups of the population
(e.g., interventions to reduce the social gradient
in smoking, obesity prevention in children,
interventions delivered by lay health
workers [15, 18–20]).
In the PRISMA-E 2012 Statement we had a third type
of systematic review focused on health equity, those that
are not aimed at reducing inequities but where it may be
important to understand the equity effects. For example,
we had previously categorized the review examining lay
health workers in this category. We have now grouped
this review into the second type of review described
above.
In 2010, approximately 20 % of systematic reviews
indexed in Medline met at least one of the above criteria
[21, 22]. These reviews may not include equity as an
outcome, but may target disadvantaged populations, or
assess differences of the effect of the intervention among
disadvantaged populations.
The PRISMA-E 2012 items are focused on health
equity but may also apply to systematic reviews in non-
health areas which address questions about inequity
such as education, transport, justice, or social welfare.
Additionally, some items in the checklist may be rele-
vant to all systematic reviews, but have been included in
this extension because of their specific importance to
health equity. These items are additions or modifications
to the existing PRISMA Statement items, in order to in-
corporate a focus on equity. For each item, the original
PRISMA item is listed and the PRISMA-E 2012 exten-
sion item is noted below.
Box 1: Terminology related to disadvantaged populations
To describe the populations who are experiencing inequitable
differences we use the term ‘disadvantaged’ although we recognize
that this term may not be acceptable to all. In a methodology
review of equity assessment, disadvantage was defined in terms of
the avoidability or preventability of health inequalities (12 of 34
studies) [11] by focusing on populations that have experienced
health inequities (e.g., Aboriginal populations).
We have chosen to use the term “disadvantaged” for PRISMA-E 2012
because we felt that despite its limitations (e.g., that it may be considered
a condescending or paternalistic term), the term “disadvantaged” more
clearly defines a population that is experiencing or has experienced health
inequities. Whereas vulnerability encompasses a combination of risk,
exposure and resilience that do not always lead to health inequities,
and other terms such as “marginalized” are too narrowly focused
and do not encompass the breadth of settings, contexts and health
inequities of interest.
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Methods PRISMA-E 2012 reporting guideline
To develop the PRISMA-E 2012 reporting guideline, we
followed the series of steps recommended by Moher and
colleagues (2010), as reported in the previously pub-
lished paper [23]. The first step was to identify need and
review the literature. We conducted a systematic review
and a methodological study [22, 24]. Next, we conducted
an online survey whose respondents included systematic
review authors, policy makers, and systematic review
funders [15]. Finally, we held a consensus meeting of
international experts from February 9–10, 2012 at the
Rockefeller Foundation’s Bellagio Conference Centre in
Bellagio, Italy. We took detailed minutes at the meeting
and used these minutes to revise the PRISMA-E state-
ment and develop this explanation and elaboration
document. The complete PRISMA-E 2012 checklist is
provided in Table 1.
How to use this paper
The format of this document is similar to the format
used in other explanation and elaboration documents
[25–29]. We feel this explanation and elaboration paper
is an important contribution to the literature because it
provides the detailed rationale, evidence, whenever avail-
able, and an exemplar, for recommending each item as
well as examples of good practice. We recommend
authors use this document in conjunction with the
PRISMA-E 2012 statement and with the original
PRISMA statement and explanation and elaboration pa-
pers. We use the term “we” to refer to the consensus
panel that met to finalize the PRISMA-Equity 2012
reporting guidelines in February 2012, as well as those
who were unable to attend but contributed to the final
reporting guidelines.
Item 1: title
Standard PRISMA item: Identify the report as a system-
atic review, meta-analysis or both.
In addition, for equity-focused systematic reviews: Iden-
tify equity as a focus of the review, if relevant, using the
term equity
Examples
○ “Inequity in childhood immunization in India: a
systematic review” [30]
○ “Can cost-effectiveness analysis integrate concerns
for equity? Systematic review” [31]
Explanation - Equity-focused systematic reviews need
a concise title that includes the term ‘equity’ or ‘in-
equity’. At the consensus meeting, the panel felt strongly
that a consistent term was needed in the title to help
identify equity-focused reviews and we chose the term
‘equity’ because of our focus on unfair inequalities in
health. Indexing of electronic databases is poor for terms
relating to health equity or disadvantaged or vulnerable
populations therefore we suggest including ‘equity’ in
the title will facilitate searching for equity-focused re-
views. Not all systematic reviews will include equity in
the title so to improve searchability, ‘equity’ should be in-
cluded in the abstract and/or keywords. This will also
help policy makers find equity-focused systematic re-
views. In a search of systematic reviews published in the
last year in MEDLINE, we only found 11 with ‘equity’ in
the title and 73 with equity in the title and/or abstract
(Additional file 1: Table S1).
Item 2: abstract
Standard PRISMA item: Provide a structured summary
including, as applicable: background; objectives; data
sources; study eligibility criteria, participants, and inter-
ventions; study appraisal and synthesis methods; results;
limitations; conclusions and implications of key findings;
systematic review registration number.
In addition, for equity-focused systematic reviews: State
research question(s) related to health equity.
Example
○ “We aimed to systematically assess current evidence
for the association between socioeconomic position
(SEP) and caries. We included studies investigating the
association between social position (determined by own
or parental educational or occupational background, or
income) and caries prevalence, experience, or
incidence” [32].
“Our primary outcome is the utilization of [post-natal
care] PNC services, and determinants of concern are:
1) socioeconomic status (for example, income,
education); 2) geographic determinants (for example,
distance to a health center, rural versus urban
residence); and 3) demographic determinants (for
example, ethnicity, immigration status)” [33]
Explanation - The abstract of the review needs to indi-
cate whether the research questions and objectives are
of relevance to equity or specific populations since some
readers, including those making decisions about health
programs and policies, may only have access to the ab-
stract (or only read the abstract). Thus, we recommend
research questions related to health equity should be re-
ported in the abstract to facilitate their retrieval for
decision-making. We also recommend describing the
type of inequities addressed by the review (e.g., health
outcomes, health service coverage or access, financial
risk).
Item 2A: in addition, for equity-focused systematic
reviews: Present results of health equity analyses (e.g.,
subgroup analyses or meta-regression).
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Table 1 Checklist of items for reporting equity-focused systematic reviews
Section Item Standard PRISMA Item Extension for Equity-Focused Reviews
Title
Title 1 Identify the report as a systematic review,
meta-analysis, or both.
Identify equity as a focus of the review,
if relevant, using the term equity.
Abstract
Structured summary 2 2. Provide a structured summary including,
as applicable: background; objectives; data
sources; study eligibility criteria, participants,
and interventions; study appraisal and synthesis
methods; results; limitations; conclusions and
implications of key findings; systematic review
registration number.
State research question(s) related to health equity.
2A Present results of health equity analyses
(e.g., subgroup analyses or meta-regression).
2B Describe extent and limits of applicability to
disadvantaged populations of interest.
Introduction
Rationale 3 Describe the rationale for the review in the
context of what is already known.
Describe assumptions about mechanism(s) by which
the intervention is assumed to have an impact on
health equity.
3A Provide the logic model/analytical framework, if done,
to show the pathways through which the intervention
is assumed to affect health equity and how it was
developed.
Objectives 4 Provide an explicit statement of questions
being addressed with reference to PICOS.
Describe how disadvantage was defined if used as
criterion in the review (e.g., for selecting studies,
conducting analyses, or judging applicability).
4A State the research questions being addressed with
reference to health equity
Methods
Protocol and registration 5 Indicate if a review protocol exists, if and where
it can be accessed (e.g., web address), and, if
available, provide registration information
including registration number.
Eligibility criteria 6 6. Specify study characteristics (e.g., PICOS,
length of follow-up) and report characteristics
(e.g., years considered, language, publication status)
used as criteria for eligibility, giving rationale.
Describe the rationale for including particular
study designs related to equity research questions.
6A Describe the rationale for including the outcomes
(e.g., how these are relevant to reducing inequity).
Information sources 7 Describe all information sources (e.g., databases
with dates of coverage, contact with study authors
Describe information sources (e.g., health, non-health,
and grey literature sources) that were searched that
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Table 1 Checklist of items for reporting equity-focused systematic reviews (Continued)
to identify additional studies) in the search and date
last searched.
are of specific relevance to address the equity
questions of the review.
Search 8 Present full electronic search strategy for at least
one database, including any limits used, such that it
could be repeated.
Describe the broad search strategy and terms used
to address equity questions of the review.
Study selection 9 State the process for selecting studies (i.e., screening,
eligibility, included in systematic review, and, if applicable,
included in the meta-analysis).
Data collection process 10 Describe method of data extraction from reports
(e.g., piloted forms, independently, in duplicate) and
any processes for obtaining and confirming data
from investigators.
Data items 11 List and define all variables for which data were sought
(e.g., PICOS, funding sources) and any assumptions
and simplifications made.
List and define data items related to equity, where such
data were sought (e.g., using PROGRESS-Plus or other
criteria, context).
Risk of bias in individual studies 12 Describe methods used for assessing risk of bias of
individual studies (including specification of whether
this was done at the study or outcome level), and
how this information is to be used in any data synthesis.
Summary measures 13 State the principal summary measures (e.g., risk ratio,
difference in means).
Synthesis of results 14 Describe the methods of handling data and combining
results of studies, if done, including measures of consistency
(e.g., I2) for each meta-analysis.
Describe methods of synthesizing findings on health
inequities (e.g., presenting both relative and absolute
differences between groups).
Risk of bias across studies 15 15. Specify any assessment of risk of bias that may affect
the cumulative evidence (e.g., publication bias, selective
reporting within studies).
Additional analyses 16 Describe methods of additional analyses (e.g., sensitivity
or subgroup analyses, meta-regression), if done, indicating
which were pre-specified.
Describe methods of additional synthesis approaches
related to equity questions, if done, indicating which
were pre-specified
Results
Study selection 17 Give numbers of studies screened, assessed for eligibility,
and included in the review, with reasons for exclusions at
each stage, ideally with a flow diagram.
Study characteristics 18 For each study, present characteristics for which data were
extracted (e.g., study size, PICOS, follow-up period) and
provide the citations.
Present the population characteristics that relate to the
equity questions across the relevant PROGRESS-Plus or
other factors of interest.
Risk of bias within studies 19 Present data on risk of bias of each study and, if available,
any outcome level assessment (see item 12).
Results of individual studies 20 For all outcomes considered (benefits or harms), present,
for each study: (a) simple summary data for each intervention
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Table 1 Checklist of items for reporting equity-focused systematic reviews (Continued)
group; (b) effect estimates and confidence intervals, ideally
with a forest plot.
Synthesis of results 21 Present results of each meta-analysis done, including
confidence intervals and measures of consistency.
Present the results of synthesizing findings on
inequities (see 14).
Risk of bias across studies 22 Present results of any assessment of risk of bias across
studies (see item 15).
Additional analysis 23 Give results of additional analyses, if done (e.g., sensitivity
or subgroup analyses, meta-regression [see item 16]).
Give the results of additional synthesis approaches
related to equity objectives, if done, (see 16).
Discussion
Summary of evidence 24 Summarize the main findings including the strength of
evidence for each main outcome; consider their relevance
to key groups (e.g., health care providers, users, and policy makers).
Limitations 25 Discuss limitations at study and outcome level (e.g., risk of bias),
and at review-level (e.g., incomplete retrieval of identified research,
reporting bias).
Conclusions 26 Provide a general interpretation of the results in the context of
other evidence, and implications for future research.
Present extent and limits of applicability to
disadvantaged populations of interest and describe
the evidence and logic underlying those judgments.
26A Provide implications for research, practice, or policy
related to equity where relevant (e.g., types of research
needed to address unanswered questions).
Funding
Funding 27 Describe sources of funding for the systematic review and other
support (e.g., supply of data); role of funders for the systematic review.
This checklist should be read in conjunction with the Statement and Explanation and Elaboration document
PICOS participants, interventions, comparisons, outcomes, and study design
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Example
○ “No strong evidence of differential effects was found
for smoking restrictions in workplaces and public
places, although those in higher occupational groups
may be more likely to change their attitudes or
behaviour. Smoking restrictions in schools may be
more effective in girls. Restrictions on sales to minors
may be more effective in girls and younger children.
Increasing the price of tobacco products may be more
effective in reducing smoking among lower income
adults and those in manual occupations, although there
was also some evidence to suggest that adults with
higher levels of education maybe more price sensitive.
Young people aged under 25 are also affected by price
increases, with some evidence that boys and non-white
young people may be more sensitive to price” [18].
Explanation - Findings related to equity questions
should be presented in the abstract along with the main
results. In addition, the abstract needs to differentiate
between the main analyses and other analyses as well as
any null findings. Of 182 abstracts, 42 % do not describe
the direction of the main effect in words, and 25 % do
not provide numerical results [34]. For equity-focused
reviews, we have found that equity findings (e.g., sub-
group analyses by socioeconomic status or other indica-
tors) are not well reported in the abstract. Including the
equity findings in the abstract may facilitate finding
equity-focused reviews. As mentioned above, some
readers only read or have access to the abstract. We
felt that including equity-findings in the abstract will
be helpful for users to determine whether the review
is of interest. Therefore, the abstract should describe
all relevant effects on health equity, both beneficial
and harmful, as well as the methods used to assess
health equity [35].
As recommended by PRISMA for abstracts [36], au-
thors should report the main results in both numbers
and words to meet the needs of different users.
Item 2B: in addition, for equity-focused systematic re-
views: Describe extent and limits of applicability to dis-
advantaged populations of interest.
Example
○ “Conditional cash transfer programmes have
been the subject of some well-designed evaluations,
which strongly suggest that they could be an effective
approach to improving access to preventive services.
Their replicability under different conditions - particularly
in more deprived settings - is still unclear because they
depend on effective primary health care, and mechanisms
to disburse payments. Further rigorous evaluative
research is needed, particularly where [conditional cash
transfers] CCTs are being introduced in low income
countries, for example in Sub-Saharan Africa or South
Asia.” [37]
Explanation - Since the abstract may be all that a
reader accesses, it is important that the abstract reports
the extent and limits of applicability of the findings of
the review in relation to equity concepts. We felt this in-
formation is important to all consumers and users of the
review, including patients, practitioners, policy makers,
press, and the public.
The reporting of applicability is not intended to be a
recommendation for practice or policy. It is instead
intended to provide the reader with information regard-
ing the primary studies and the results of the review and
how the results of equity considerations apply. While
there is insufficient space to report applicability consid-
erations for all populations, we felt that applicability to
the target population of the review should be reported.
Introduction section
Item 3: rationale
Standard PRISMA item: Describe the rationale for the
review in the context of what is already known.
In addition, for equity-focused systematic reviews:
Describe assumptions about mechanism(s) by which the
intervention is assumed to have an impact on health
equity.
Examples
○ “CCT programs are justified on the grounds that
demand-side subsidies are needed to address con-
straints and bottlenecks of service delivery. CCT pro-
grams usually aim to increase demand for preventive
health services and education because these services
have positive spillover effects that justify the expense.
CCT help overcome barriers to access of services.
These programs address social equity concerns because
CCT can help to “level the playing field” thus creating
equal opportunities” [37].
○ “Many lay health worker programs aim to address
inequity by providing services to underserved
communities” [38].
Explanation - If available, systematic reviews with a
focus on health equity should explicitly describe the as-
sumptions about the effects of the intervention on
health equity, or drivers of health inequity. Assumptions
about outcomes along the causal chain and these hy-
potheses about health equity may be articulated using
different methods such as a program theory and can
then be tested empirically with pre-planned analyses in
the review [39, 40]. The review should describe a priori
how and why interventions are expected to work and
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the influence of factors such as setting and participant
and program characteristics. This explicit reporting of
assumptions and underlying hypotheses will help the
reader understand the choice of methods to assess ef-
fects on health equity and the interpretation of results
within the framework of these hypotheses.
Item 3A: in addition, for equity-focused systematic
reviews: Provide the logic model/analytical framework, if
done, to show the pathways through which the interven-
tion is assumed to affect health equity and how it was
developed.
Examples
Figure 1 [41, 42]
Figure 2 [43]
Explanation - Health equity is influenced by multiple
interacting factors such as context, setting, population
characteristics, environment, public policy setting, health
facility factors, health provider factors [4, 44, 45]. A vis-
ual framework, or logic model, can show the links be-
tween these factors, the program or intervention of
interest, and the hypothesized effects on health equity. It
can be used to show hypothesized pathways of influence
on health equity, to focus the review, define the inclu-
sion criteria, identify intermediate outcomes and harms,
define the search strategy, and plan subgroup and effect
modifier analyses [46]. For example, the logic model for
a systematic review of preschool feeding shows that low
socioeconomic status and household size may increase
the risk of substitution (less food at home), thus decreas-
ing the observed effects of preschool feeding) [47]. A vis-
ual framework can be useful for policy-makers and
decision-makers who seek to answer questions about the
effects of both targeted and universal interventions and
how these programs will work in their policy/decision-
making settings and system. For complex interventions,
a visual framework can help the reader unpack the ‘black
box’, thus showing how the intervention might affect dif-
ferent subgroups of the population and can be used as a
tool for articulating subgroup analyses a priori.
Many different methods exist for developing a logic
model, and different logic models have been developed
for the same question. Guidance for how to construct a
logic model is available from the Cochrane Public Health
Group and the Kellogg Foundation [48–51].
Item 4: objectives
Standard PRISMA item: Provide an explicit statement of
questions being addressed with reference to participants,
interventions, comparisons, outcomes, and study design
(PICOS).
In addition, for equity-focused systematic reviews:
Describe how disadvantage was defined if used as
criterion in the review (e.g., for selecting studies, con-
ducting analyses, or judging applicability).
Example
○ “For the purposes of this review, the
term’disadvantaged’ is taken to denote women
whom the primary investigators considered to
be of low socio-economic status or educationally
disadvantaged, or who are under the age of
20[children born to teenage mothers in the
UK have been estimated to have a 63 % increased
likelihood of being born into poverty], or who
are caring for children in single-parent
households” [55].
○ “Parents with children up to the age of school
entry and who were socially disadvantaged in
respect of poverty, lone parenthood or ethnic minority
status.” [17]
Fig. 1 Item 3A, Example 1 – Analytic Framework. This is an example of a “funnel of attrition” [41, 42]
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○ “We will retrieve studies implemented in LMICs, as
defined by The World Bank Group’s classification…
which study access to or utilization of PNC services by
birthing women living in resource strained settings.” [33]
Explanation - Description of the specific population in
the PICOS (Population, Intervention, Comparator, Out-
come, Study Design) framework does not encompass ex-
plicit definition of how disadvantage or risk of inequity
will be assessed, for example in reference to which
group, disadvantaged by what mechanisms, and for
which outcomes. Populations are at risk of health disad-
vantage for many different reasons which may interact
with each other. There are many examples of factors
that may contribute to disadvantage and these may
interact with each other, such as geographical isolation,
lack of access to health facilities, biologic vulnerability,
historical oppression, social exclusion, health or lan-
guage literacy, low resource settings, inadequate health
systems, inadequate health insurance, health provider at-
titudes, stigmatization, and discrimination [6]. System-
atic review authors can group such factors using the
PROGRESS-Plus acronym; Place of residence, Race/ethni-
city/culture/religion, Occupation, Gender/sex, Religion,
Social Capital, Socioeconomic status [6, 52]. However,
grouping populations that share one characteristic across
PROGRESS-Plus may lead to overgeneralization since
people within one category are heterogeneous (e.g.,
women range from poor to wealthy, with very different
personal histories and exposures to health risks).
An explicit definition of how disadvantage will be
assessed in the systematic review, either for targeted in-
terventions or for subgroup analyses of universal inter-
ventions, is necessary to increase the likelihood that
similar groups of people are compared, to make explicit
the proposed reasons those people are considered disad-
vantaged, to explain why and how the program is ex-
pected to work for people at different risk of health
disadvantage, and to facilitate judgments about applic-
ability in different settings and populations. If disadvan-
tage is used as a criterion, it needs to be defined, as well
as the proposed reasons for disadvantage (e.g., biologic,
societal), and the comparator or reference group against
which disadvantage is assessed. Disadvantage and vul-
nerability may be poorly reported in primary studies.
However, systematic review authors should describe how
they have operationalized their definition of disadvantage
or inequity in their inclusion criteria, analyses, and
Fig. 2 Item 3A, Example 2 – Analytic Framework. This is an example of a logic model [43]
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judgements of applicability. For example, if economically
disadvantaged populations are the focus of the review,
then a description of this population should be provided.
Item 4A: in addition, for equity-focused systematic re-
views: State the research questions being addressed with
reference to health equity.
Examples
○ 2 objectives “To determine the effectiveness of school
feeding programs in improving physical and
psychosocial health outcomes for low income school
children.” And “To compare the effectiveness of school
feeding programmes for socio-economically disadvan-
taged children and advantaged children” [53].
○ “To assess the impact on maternal and infant health
and on infant development of programmes offering
home support in addition to the standard service for
teenaged mothers (ages less than 20 years) who had
recently given birth and who were socially or
economically disadvantaged, for example because they
were poor, lived inner city or were single parents” [54].
Explanation - If assessing the impact on inequities is
an objective of the review, the research questions related
to this objective should be stated. Potentially important
subgroup effects are differences in the relative effect that
are large enough that users might make different deci-
sions based on the subgroup effect than they would be
based on the overall effect. Review authors should give
consideration to all potentially disadvantaged groups for
which the intervention might have a different effect
based on the intervention’s mechanism of action; includ-
ing economic status, employment or occupation, educa-
tion, place of residence, gender, and ethnicity.
Consideration of differences in relative effects for dis-
advantaged populations should be addressed similarly to
any other subgroup analysis. As such, authors should
distinguish between protocol and review items. The
protocol should indicate plans for any subgroup ana-
lyses, including specifying which subgroups will be in-
vestigated, the predicted direction of the subgroup
effect, and the indirect evidence supporting the predic-
tion (e.g., biological or sociological rationale; studies of
other relevant populations, interventions or outcomes)
[55, 56]. Only a small number of subgroups (i.e., only
those for which there is a plausible reason such as indir-
ect evidence for anticipating a subgroup effect) should
be investigated.
Methods section
Item 6: eligibility criteria
Standard PRISMA item: Specify study characteristics (e.g.,
PICOS, length of follow up) and report characteristics (e.g.,
years considered, language, publication, status) used as cri-
teria for eligibility, giving rationale.
In addition, for equity-focused systematic reviews:
Describe the rationale for including particular study
designs related to equity research questions.
Examples
○ “Cross-sectional quantitative study designs,
qualitative study designs, or a combination of the two
(mixed-methods studies). Specifically, we included,
first, any type of cross-sectional study design reporting
quantitative data. Second, qualitatively-based studies
had to have used either individual interviews or focus
group interviews to collect data about [female genital
mutilation/cutting] FGM/C and used qualitative data
analysis methods, such as thematic analysis, to be
eligible for inclusion. Third, mixed-methods studies
that incorporated both quantitative and qualitative
components where the research design matched the
nominated study designs were included. Both the
quantitative and the qualitative components of the
study were subjected to the same inclusion criteria as
the mono-methods studies and the study was only
included when the inclusion criteria were met” [57].
○ “We included qualitative studies and studies using
descriptive statistics which met the following criteria:
1. reported on interventions as identified as “farmer
field schools”, although not necessarily the same
interventions as those included in the review of
effects (review question 1);
2. assessed determinants of service delivery quality,
knowledge acquisition, adoption of technological
improvements, diffusion, or sustainability (either
directly or indirectly – for example, studies that
were relevant to addressing barriers to and enablers
of [farmer field schools] FFS effectiveness)…” [58]
Explanation - Evidence on equity impacts may come
from a range of study designs, depending on the
question, and the study designs included in a system-
atic review should be chosen based on the question
according to their ‘fitness for purpose’ [59]. The evi-
dence of effects may have been assessed using RCTs
or other intervention study designs such as inter-
rupted time series or controlled before-after study.
However, for many equity-focused reviews examining
social or public health interventions, the context in
which the intervention operates is important and may
be reported in qualitative studies [59]. Evaluations of
policy-level and other interventions that have implica-
tions for reducing inequity and may provide import-
ant insight into the effects on equity may have been
evaluated using non-randomised designs (e.g., natural
experiments).
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Authors should be able to capture different types of
evidence through the inclusion of different study de-
signs, but should justify inclusion of these designs and
provide the rationale. For example, barrier and facilitator
data collection and analysis often requires quantitative
and qualitative data. New authors may not be aware of
the rationale for preferred study designs. While most
systematic reviews just list study design without ration-
ale, the need to explain the rationale is not just an issue
for equity, it should always be reported.
Item 6A: in addition, for equity-focused systematic re-
views: Describe the rationale for including the outcomes
(e.g., how these are relevant to reducing inequity).
Examples
○ “Other smoking-related outcomes included compli-
ance with age-of-sale legislation, density of advertising
and vending machines, brand appeal, and awareness
and receptivity to antismoking campaigns. This broad
range of smoking-related outcomes was included in
order to encompass the diverse ways in which tobacco
control policies can influence youth smoking-related
outcomes” [60].
○ “Changes in equity of access - increased access for
disadvantaged groups or a reduction in gaps in
coverage – could also be an important outcome
measure. This required a preliminary analysis and
categorisation of the population of interest along a
socio-economic scale. We accepted any relevant
methodology (e.g., wealth/asset index) provided it was
rigorous and described in detail” [37].
Explanation - As with all systematic reviews, out-
comes need to be selected based on their relevance to
the relevant stakeholder and/or user group (e.g., subjects/
patients, practitioner (and the patient-practitioner dyad),
the public, policy-makers and politicians). Equity-focused
systematic reviews must, in addition, consider the rele-
vance and importance of outcomes across categories of
disadvantage that are deemed relevant for the review, in-
cluding both health and non-health outcomes. Non-health
related outcomes can have direct impacts on health and
equity. For example, the Whitehall study found that em-
ployment grade levels are related to health differences in
which people with lower grade jobs have higher rates of
mortality and diseases, such as ischaemic heart disease,
and lower self-perceived health status [61].
In addition, measures may need to be developed
and/or adapted to ensure that the methodology does
not disadvantage participation of bias results across
populations. Other situations are often found when a
measure may be used across a population, and where
the intervention effectiveness is analysed according to
cultural diversity within the population. For example,
a systematic review of culturally appropriate health
education assessed the influence of culturally adapted
measurement tools on knowledge outcomes using
sensitivity analysis [62]. The importance of outcomes
for different settings and populations needs to be
rated when selecting major outcomes, for example, in
Summary of Findings (SOF) Tables for Cochrane re-
views. A SOF table presents the main findings of the
review for up to seven patient-important outcomes
and rates the quality of the evidence [63]. SOFs are
intended for those using the review, such as decision-
makers [64].
Context, inconvenience and burden (e.g., financial bur-
den) for populations need to be considered as potentially
important outcomes in equity-focused reviews even if
they are not commonly reported in primary studies. Fi-
nancial burden may be relatively greater for those who
are poor and other burdens, such as stigma or travel
time, may be different for different populations.
Equity of access to care and coverage of health services
are important outcomes for some interventions which
seek to improve access. Horizontal equity implies equal
health care for equal need, whereas vertical equity im-
plies greater health care for greater need. Authors
should take a pragmatic approach to assessing equity of
access.
Item 7: information sources
Standard PRISMA item: Describe all information sources
(e.g., databases with dates of coverage, contact with study
authors to identify additional studies) in the search and
date last searched.
In addition, for equity-focused systematic reviews: De-
scribe information sources (e.g., health, non-health, and
grey literature sources) that were searched that are of
specific relevance to address the equity questions of the
review.
Examples
○ “We chose to restrict our search of electronic
databases to the 20 databases that had produced the
highest yield in the search for a previous systematic
review on a related topic, the health effects of new
roads. We developed our search syntax iteratively. We
first conducted a scoping search with a provisional set
of terms, retrieved the 100 most relevant abstracts, and
then added additional indexing or text word terms used
in those references to our search strategy. We then
adapted the search syntax for each database or
interface used. We did not limit the search using terms
for study design. We decided not to attempt a
“systematic” internet search. Instead, we used three
quality assured gateway sites...and our own knowledge
to generate lists of potentially relevant web sites, from
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which we selected a purposive sample of 16 sites that
contained bibliographies or searchable databases of
documents. These represented a range of types of
organisation (academic, government, and voluntary),
countries of origin (Canada, all the countries of the
European Union, Norway, and the United States of
America), and language of publication (Danish, English,
French, Norwegian, and Swedish)” [65].
○ “We searched the following electronic databases for
primary studies:
The Cochrane Central Register of Controlled Trials
(CENTRAL) 2009, Issue 1, part of the The Cochrane
Library (www.thecochranelibrary.com) including the
Cochrane Effective Practice and Organisation of Care
(EPOC) Group Specialised Register (searched 3
March 2009)
MEDLINE, Ovid In-Process & Other Non-Indexed
Citations and MEDLINE, Ovid (1948 to present)
(searched 24 June 2011)
EMBASE, Ovid (1980 to 2009 Week 09) (searched 2
March 2009)
PsycINFO, Ovid (1806 to February Week 4 2009)
(searched 4 March 2009)
EconLit, Ovid (1969 to February 2009) (searched 5
March 2009)
Sociological Abstracts, CSA (1952 to current)
(searched 8 March 2009)
Social Services Abstracts, CSA (1979 to current)
(searched 8 March 2009)
LILACS (searched 6 May 2009)
WHOLIS (searched 7 May 2009)
World Bank
Science Citation Index Expanded (SCI-EXPANDED)
(1975 to present) (searched 8 September 2010)
Social Sciences Citation Index (SSCI) (1975 to
present) (searched 8 September 2010). In addition we
selected relevant databases from the LMIC database
list at: http://epocoslo.cochrane.org. We did not
search CINAHL or International Pharmaceutical
Abstracts, so it is possible that studies relating to
nursing or pharmaceuticals were missed. However,
the general searches, including in websites focused on
this topic, did not suggest that we had missed any
relevant studies. We will add these databases when
the review is updated” [66].
Explanation - Equity-focused reviews often go be-
yond issues of health and bridge other disciplines and
thus information sources. For equity-focused system-
atic reviews, sources of information beyond the well-
known health databases may be required. The search
strategy may require inclusion of sources of informa-
tion from different disciplines and different databases
(e.g., sociological abstracts, IDEAhealth, non-health
transportation or environmental content databases, and
discipline-specific grey literature). Authors should
describe all sources of information used for the
search and provide a brief description of each, and justify
why these information sources were considered necesary
and appropriate.
Some relevant information may be available only to
members of a certain association or working group.
It would therefore be helpful for authors to report
the accessibility of the sources of information in
addition to website links or other information that
may help the reader identify where the information
has originated.
Item 8: search
Standard PRISMA item: Present full electronic search
strategy for at least one database, including any limits
used, such that it could be repeated.
In addition, for equity-focused systematic reviews: De-
scribe the broad search strategy and terms used to ad-
dress equity questions of the review.
Example
○ See Additional file 1: Table S2
Explanation - Authors of equity-focused systematic re-
views should report the search strategy and search terms
used to identify sources relevant to the equity questions.
Equity questions may require comprehensive textword
searches to identify specific populations, multi-component
interventions or settings of interest which may require
combinations of text words. Additionally, equity relevant
reviews may relate to stigmatized populations, where
language has evolved in order to identify the commu-
nities in a non-stigmatized way. Any search terms
used should be clearly reported to ensure that the
reader can duplicate the search. We do not suggest
limiting the search to equity-relevant terms unless
these equity search strategies have been validated. For
example, the Cochrane Child Health filter has been
validated [67]. Other validated search filters are collected
in a repository by the InterTASC Information Specialists'
Sub-Group Search Filter Resource. There is also ongoing
work to validate a filter for identifying sex-specific
analyses [68].
Box 2 A note about searching
Caution should be used when developing the search strategy.
Limiting the search using equity-related search terms is not
recommended as many studies are not indexed using equity-
related terms and potentially relevant studies could be missed.
For equity-focused reviews, the search strategy may need to be
broadened to reduce the risk of missing potentially included
studies. Review authors should plan more time for screening.
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Item 11: data items
Standard PRISMA item: List and define all variables
for which data were sought (e.g., PICOS, funding
sources) and any assumptions and simplifications
made.
In addition, for equity-focused systematic reviews: List
and define data items related to equity, where such data
were sought (e.g., using PROGRESS-Plus or other criteria,
context).
Example
○ “…extracted data on study design, description of
the intervention (including process), details on
participants (including age, sex, number in each
group), length of intervention, definition of poor/low
income, other socio-demographic variables, including
place of residence, race/ethnicity, age, and nutritional
status, critical appraisal (see below), physical, cognitive,
and behavioural outcomes. We had planned to
extract data on cost-effectiveness, but found
none. Where possible, we recorded effects by
socio-economic position.” [53]
Explanation - It is important for equity-focused sys-
tematic reviews to report all items for which data were
sought even if the information was not available from
the primary studies. Authors should explain the reasons
for seeking data on these characteristics. If possible, au-
thors should consider making their data extraction
forms available online (e.g., as web-only appendices) or
by request so that others may use or amend the forms in
their own reviews.
Other data items that relate to the context of the
population or intervention should also be reported
as well as any interactions between context and
PROGRESS-Plus factors. Each characteristic requires
careful consideration regarding their definition and
classification as well as their interaction with other
contextual elements and how they influence health
inequities. For example, there is no agreed system
for classifying race, ethnicity, and culture, particularly
across different countries [6].
PROGRESS-Plus is one acronym that can be used
to describe disadvantage [6, 52, 69]. However, other
frameworks for describing disadvantage and inequity
exist and may also be used to capture equity-
relevant data items. We support PROGRESS-Plus be-
cause it is easy to remember and is inclusive of all
factors that may indicate disadvantage. About 68 %
of systematic reviews describe the included popula-
tion using one or more of the PROGRESS-Plus cri-
teria and 13 % assess the effects of interventions
disaggregated across one or more of these character-
istics [24].
Item 14: synthesis of results
Standard PRISMA item: Describe the methods of handling
data and combining results of studies, if done, including
measures of consistency (e.g., I2) for each meta-analysis.
In addition, for equity-focused systematic reviews:
Describe methods of synthesizing findings on health
inequities (e.g., presenting both relative and absolute
differences between groups).
Example
○” Studies demonstrating an overall effect on
anthropometric outcomes were initially categorized
according to whether they were effective or not
effective among lower SEP groups. Within these
categories, we then analysed studies to identify
common characteristics between interventions,
including the degree to which they addressed
structural barriers to behavioural change; as noted
earlier, particular structural barriers may be more or
less prevalent among different SEP groups in a
population” [70].
Explanation - There is a need for clear and explicit
reporting of choices regarding analyses about health in-
equity and their rationale a priori. This includes report-
ing what will be compared and how these comparisons
will be made. There are over 20 different approaches
available to measure health inequalities between two
groups (e.g., rate ratio, rate difference, low to high ratio),
or between more than two groups (e.g., slope index of
inequality, concentration index, index of dissimilarity)
[71]. Despite vigorous debate about the attributes, meas-
urement properties and implications of different mea-
sures and choice such as the referent group, there is no
single accepted measure of health inequalities, and all
are subject to limitations [72]. Furthermore, the selec-
tion of how to measure health inequalities may bias the
interpretation of results [71]. For example, the interpret-
ation of any measure of changes in health inequalities
over time depends on whether the outcome is an ad-
verse effect or beneficial outcome, and on the baseline
prevalence [73]. Authors should report the methods used
to synthesize findings to ensure sufficient information.
Figure 3 [18]
Measures of health inequalities may be useful as an
input for population or economic models for project-
ing population impact on health inequalities. Consid-
erations for choosing a measure of health inequalities
are: 1) interpretability; 2) ease of calculation; and 3)
information available from primary studies. While
there is no agreement on the best approach, selection
of measures of health inequalities needs to consider
the advantages, data requirements and limitations of
these approaches. The choice of reference point
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(comparator), method of assessing differences (relative
or absolute), measurement of differences or end of
study outcomes affects the difference observed be-
tween two or more groups [74]. Some measures (e.g.,
Gini, concentration index) may be less well under-
stood by the users.
The measurement of health inequity depends on char-
acteristics of the outcome measure and choices about
comparisons, such as, whether the outcome is desirable
or undesirable, baseline prevalence, and absolute or rela-
tive differences [74, 75]. This was demonstrated with a
before-after study of a coronary artery bypass graft
(CABG) report card program that compared the rates of
CABG surgery between white, black, and Hispanic pa-
tients. The relative difference decreased between white
and black patients for receipt of a CABG but the abso-
lute difference increased therefore increasing the dispar-
ities between ethnicities [75, 76].
The absolute effect provides the difference in effective-
ness between while the relative effect describes the dif-
ference in effectiveness relative to a reference group,
such as the whole population [77]. Absolute differences
can describe the proportion of the disadvantaged popu-
lation affected, or not affected, by the intervention since
disadvantaged populations may have worse health status
and higher risk of adverse outcomes [75]. Another
example (Fig. 2) demonstrates that while the rate of
stomach cancer mortality for men and women declined
between the years 1930 and 2000, the absolute difference
between these rates decreased over that last 50 years
while the relative difference has increased steadily [78].
This demonstrates that although mortality rates have de-
clined in both groups, the ratio of male-to-female stom-
ach cancer mortality has increased (more men than
women are dying from stomach cancer). It would be
misleading to present one of these indicators without
the others therefore we suggest that systematic review
authors present the absolute and relative differences.
If the aim of the intervention being studied in the sys-
tematic review is to reduce inequities, authors should re-
port how they plan to measure the effect on health
inequities. If the review will compare effects in two
groups, how will the difference be measured, synthe-
sised, and interpreted at the systematic review level?
Figure 4 [78]
Item 16: additional analyses
Standard PRISMA item: Describe methods of additional
analyses (e.g., sensitivity or subgroup analyses, meta-
regression), if done, indicating which were pre-specified.
In addition, for equity-focused systematic reviews:
Describe methods of additional synthesis approaches
Fig. 3 Harvest Plot. The ‘harvest plot’ synthesizes and displays the evidence to support possible social gradients in the effects of the intervention [18]
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related to equity questions, if done, indicating which
were pre-specified.
Examples
○ “Effect modifiers, such as high/low energy,
compliance, substitution, and duration of the
intervention were examined. In addition, study quality
was considered since studies of lower quality often
show higher effect sizes than those of higher quality.
For example, biased outcome assessment is possible if
the outcome assessors are not blinded to study group.
This review tabulated the effects for each study by
sorting them according to these effect modifiers (type
of study, blinding versus unclear blinding, date of
study, and high versus low energy) (Kristjansson et al.
2007). The effect of school feeding on learning
outcomes may also be affected by contextual factors as
teacher absenteeism and availability of learning
materials, both of which may be worse in more
disadvantaged communities.” [53]
○ “This study examined the influence of program
implementation, program activities, program
environment, and individual characteristics on welfare-
to-work programs. The authors also considered the
unemployment rate for each to determine whether the
programs were affected by the availability of jobs in the
area in which the program was implemented” [79].
Explanation - Understanding how to reduce health in-
equities may require additional quantitative or qualita-
tive analyses, such as causal pathway analyses or process
evaluations and a greater use of subgroup analyses to
explore the differential effects of public health or
population level interventions. Implementation of an
intervention and its effectiveness may depend on partici-
pant characteristics such as age, education, gender, social
status, context including the presence of complementary
services, setting characteristics, and intervention character-
istics (e.g., fidelity of intervention, delivery). Differences in
participant characteristics, context and intervention design
or delivery may limit the ability to conduct a meta-
analysis. These characteristics of interventions, setting
and participants may not be well-reported in primary
studies, or have insufficient statistical power to find
significant effects at the sub-group level [80, 81]. System-
atic review authors may need to contact the primary study
authors for information regarding subgroup analyses
across different characteristics such as ethnicity and socio-
economic status. This information may have been ana-
lysed but not reported in the published papers [82, 83].
The move towards open access of trial data may make this
more feasible in the future [84].
Subgroup analyses need to be conducted with caution
and follow guidelines for reducing the likelihood of false
results. Sun and colleagues have developed criteria for
judging the credibility of subgroup analyses such as pre-
specifying the hypothesized direction of effects, using a
test for interaction, and keeping the number of subgroup
analyses few, and justified based on prior empiric evi-
dence [55].
Systematic reviews with an equity focus should docu-
ment and describe relevant and important characteristics
of the participants and settings, as well as implications
for the ability to conduct pre-planned analyses.
Numerous additional methods may be employed to
assess the influence of contextual factors, participant
Fig. 4 Absolute and Relative Gender Disparity in Stomach Cancer Mortality, 1930–2000 [78]
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characteristics and implementation such as qualitative
review methods to understand the process of imple-
mentation and its relationship to effectiveness (e.g.,
using meta-ethnography, realist review or thematic ana-
lysis) [85]. When reporting the use of these methods, au-
thors should use the relevant, method-specific reporting
guidance to transparently report their methods (e.g.,
RAMESES reporting guidelines for realist review or the
Cochrane Handbook extension on qualitative reviews)
[86, 87].
Results section
Item 18: study characteristics
Standard PRISMA item: For each study, present charac-
teristics for which data were extracted (e.g., study size,
PICOS, follow-up period) and provide the citations.
In addition, for equity-focused systematic reviews:
Present the population characteristics that relate to the
equity questions across the relevant PROGRESS-Plus or
other factors of interest.
Examples - Present the population characteristics that
relate to the equity questions across the relevant
PROGRESS-Plus or other factors of interest.
○ “Of the 82 studies included in this review, 55 studies
(67 %) were conducted in six high income countries:
Australia, Canada, Ireland, New Zealand, the UK, and
the USA. Forty-one of the 82 studies were conducted
in the USA. Twelve studies (14.6 %) were conducted in
eight middle income countries (Brazil, China, India,
Mexico, Philippines, Thailand, Turkey, and South
Africa). Fifteen trials (18.3 %) were from 10 low income
countries Bangladesh, Burkina Faso, Ethiopia, Ghana,
Iraq, Jamaica, Nepal, Pakistan, Tanzania, and Vietnam).
In 59 studies the intervention was delivered to patients
based in their homes. Five interventions were based
solely in a primary care facility…A further eight studies
involved a combination of home, primary care, and
community based interventions. Four studies delivered
the intervention mainly by telephone…while one
implemented the intervention through community
meetings. For five studies, other sites were used such as
the workplace, churches, or homeless shelters” [38].
○ “Study participants had a mean age of 12.6 years and
were described as of American Indian descent and
representing the Pueblo, Navajo, Hopi, and Jicarilla
Apache Indian Nations. The study setting was
described as a boarding school exclusively for
American Indian youth and promoting academic
excellence” [88].
Explanation - Approximately 50 % of systematic re-
views report the effect of sex/gender on outcomes, and
less than 15 % report other PROGRESS-Plus characteris-
tics which may be important [21, 24, 89]. PROGRESS-
Plus information is reported in primary studies more
often than in systematic reviews [21, 89]. Reporting the
characteristics of populations associated with disadvan-
tage, if relevant to the SR question, helps the user/reader
compare their own setting and population to those in-
cluded in the studies and can influence decision-making.
It may be useful to include criteria relating to judge-
ments about which PROGRESS-Plus factors are relevant
for the review question. A number of frameworks are
available to help identify characteristics that are relevant
in describing the socioeconomic and demographic char-
acteristics of populations in addition to PROGRESS-
Plus, such as SCRAP (Sex, Comorbidities, Race, Age and
Physiopathology) [90]; and SUPPORT Collaboration
framework [91]. There is little empirical evidence about
the most efficient use of these frameworks. It is unlikely
to be feasible to report all characteristics of interest, and
not all characteristics may be relevant for each review. It
is not necessary to report on all PROGRESS-Plus char-
acteristics, as this might encourage data dredging. How-
ever, authors should consider which factors are relevant
to their question a priori.
Authors should report characteristics of the setting,
and whether these characteristics are entangled with the
classification of disadvantage. For example, in the sys-
tematic review of school feeding for disadvantaged chil-
dren, disadvantage was identified by attributes of the
setting such as the location (poor, rural villages), the
main occupation (e.g., subsistence farmers”) and the
presence of school breakfast programs, which were only
funded and provided in very poor areas with high mal-
nutrition [53].
Item 21: synthesis of results
Standard PRISMA item: Present results of each meta-
analysis done, including confidence intervals and mea-
sures of consistency.
In addition, for equity-focused systematic reviews:
Present the results of synthesizing findings on inequities
(see 14).
Example
○ “This review sought to identify studies which had
reported on sociodemographic characteristics known
to be important from an equity perspective. For this
process, the PROGRESS (Place, Race, Occupation,
Gender, Religion, Education, Socio-economic status
(SES), Social status) framework was utilised. All studies
reported the gender of participants at baseline. Four
studies reported the race of participants and the level
of education of parents…and two studies included
information about the employment status of parents
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at baseline… included information on SES of
participants at baseline based on parental income…
reported some indicators related to place (the proportion
of participating schools in a rural or urban region) and
SES (the proportion of participating schools in an urban
region which were also in an area considered to be
underprivileged). When analysing data on outcomes,
only three studies analysed results by any of the PRO-
GRESS items. …analysed outcomes by gender…analysed
outcomes by the same indicators of place and SES that
were collected at baseline (these data are discussed
above)” [20].
Explanation - Authors should report the results of all
analyses related to health inequities and specify which
analyses were determined a priori and which were con-
ducted post hoc. Raw values, as well as absolute and
relative effects on health inequities should be presented
for the reasons discussed above. All analyses conducted
at the review level should be reported, even if they were
lacking in data or were not statistically significant.
When examining the data across a population to iden-
tify population subgroups experiencing disadvantage, in-
terventions may have a greater absolute effect even if the
relative effect is the same. For example, a cohort of
women smokers found that the relative risk of coronary
heart disease for cigarette smokers was slightly lower
among women with hypertension, hypercholesterolemia,
or diabetes than among those without them [92]. How-
ever, the absolute (or attributable) risk was two or more
times higher for women with those conditions. Although
the relative risk was lower, the absolute risk was much
higher because the baseline risk of coronary heart dis-
ease was so much higher for non-smoking women with
those conditions [92].
A summary of findings table is a recent requirement
of Cochrane reviews which presents the main findings of
the review and the quality of the evidence [63] and are
intended for those using the review, such as decision-
makers, and also facilitate the use of the review for de-
veloping guidelines and recommendations [64]. The
Summary of Findings (SOF) table is recommended to in-
clude 7 patient-important outcomes. To appropriately
consider equity using summary of findings tables, au-
thors should consider three strategies: 1) include an out-
come related to health inequity to show whether the
intervention enhanced health equity (Table 2); [93]. 2)
consider whether disadvantaged populations have differ-
ent baseline risk of the important outcomes, and include
separate row in the summary of finding table to show
the absolute events for disadvantaged groups (Table 3);
[94] and 3) Consider whether a separate Summary of
Findings (SOF) table is needed because of expected dif-
ferences in relative effects (Table 4) [95].
Item 23: additional analyses
Standard PRISMA item: Give results of additional ana-
lyses, if done (e.g., sensitivity or subgroup analyses, meta-
regression [see Item 16]).
In addition, for equity-focused systematic reviews: Give
the results of additional synthesis approaches related to
equity objectives, if done, (see 16).
Examples
○ “Effect modifiers were age and socioeconomic status.
Younger students had larger effects than older students
and students with lower socioeconomic status (SES)
had larger effects than those with higher SES.” [96]
○ “This review used weighted regression analyses to
investigate which elements of the programs were
independently related to bullying and victimization
effect sizes. These analyses showed that the most
important elements of the program that were related to
a decrease in bullying were parent training/meetings
and disciplinary methods. Of all the intensity and
duration factors, the most important program elements
were intensity for children and parent training/
meetings.” [97]
Explanation - The results of any additional synthe-
ses related to the equity objectives should be reported
as well as whether they were planned a priori and
specified in the review protocol. This is consistent
with published best practice in subgroup analysis [55].
Subgroup analyses can be inappropriate, poorly-specified,
and prone to Type I and Type II error, therefore, aall sub-
group analyses need to be interpreted cautiously. Sub-
group analyses in systematic reviews are generally
reported with insufficient detail to judge their cred-
ibility [56].
Subgroups that were not identified at the protocol
stage may be identified post hoc, however, the rationale
for these analyses should be reported. Authors should
report all subgroup analyses and any analyses to assess
effect modifiers such as meta-regression- both statisti-
cally significant and non-significant to avoid outcome
reporting bias of reporting only statistically significant
results [98]. This may be difficult, as effect modifiers
may not be clearly reported in the primary studies. In
some cases, there may be too few studies in particular
settings of interest to draw conclusions. Intervention ef-
fects can be influenced by their design and implementa-
tion as well as the context within which it was
implemented. For example, in the school feeding review,
learning outcomes such as mathematics achievement
were found to be higher with school meals programs but
context was important for this outcome; if there were no
teachers then there was no change in educational achieve-
ment with feeding.
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Analyses related to contextual factors should be fully
reported including a description of whether data was
lacking from primary studies.
Discussion section
Item 26: conclusions
Standard PRISMA item: Provide a general interpretation
of the results in the context of other evidence, and impli-
cations for future research.
In addition, for equity-focused systematic reviews:
Present extent and limits of applicability to disadvan-
taged populations of interest and describe the evidence
and logic underlying those judgements.
Example
○ “This review included studies from high income
countries as well as lower-middle- and upper-middle-
income countries, with five studies conducted in coun-
tries within the latter two groupings (Thailand, Brazil,
Chile and Mexico). This means that, while predomin-
antly conducted within high-income settings, the find-
ings from this review may be generalisable to a number
of settings. A total of nineteen studies specifically re-
ported incorporating strategies to target socio-
economic and/or cultural diversity or disadvantage.
One such study was conducted outside of the high-
income country setting, in Chile, an upper-middle-
income country. Of the remaining eighteen studies,
seven studies conducted in the USA were of interven-
tions targeting African American children and their
communities and another two studies targeted Native
American communities. Other studies targeted partici-
pants of low socio-economic status, or were imple-
mented in areas of social disadvantage. By far the most
common setting for interventions included in this re-
view were schools (43 studies). Other interventions
were (or included) home-based (14 studies), commu-
nity based (six studies), or were set in a health service
Table 3 Example of a summary of findings table that includes a separate row to show the absolute events for disadvantaged
groups
Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age
Patient or population: Children aged between 6 months and five years
Intervention: Vitamin A supplementation
Comparison: Placebo or usual care
Outcomes Illustrative comparative risksa
(95 % CI)
Relative effect
(95 % CI)
No.
of Participants
(studies)
Quality of the
evidence
(GRADE)
Comments
Diarrhoea-
related
mortality
Low risk population RR 0.72; 95 % CI
0.57 to 0.91
90,951
(7 studies)
+++O
moderate2
Total number of participants reflects
number randomised to studies.
The analysis combined cumulative
risk and risk per/1000 years follow-up.
3 per 10001 2 per 1000 (2 to 3)
Follow-up:
48–104 weeks
Medium risk population
4 per 10001 3 per 1000 (2 to 4)
High risk population
9 per 10001 6 per 1000 (5 to 8)
[94]
Table 2 Example of a summary of findings table that includes an outcome related to health inequity
The impact of user fees on access to health services in low- and middle-income countries
Population: Anyone using any type of health service in low- and middle-income countries.
Settings: Burkina Faso, Kenya, Lesotho, Papua New Guinea.
Intervention: Introducing or increasing user fees
Comparison: No fees
Outcomes Relative change in
utilisation1
Number of
studies
Quality of the evidence
(GRADE)a
Comments
Equity outcome - health
utilisation by quartile
N/A 1 ⊕⊖⊖⊖ Very low3 This study where quality improvements
were introduced at the same time as user
fees found an increase in utilisation for poor
groups. The authors did not report the results
in a way that the relative change in utilisation
could be calculated.
[93]
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(two studies) or care setting (two studies). Eleven studies
incorporated interventions across multiple settings.” [20]
Explanation - The conclusion should provide a trans-
parent assessment of the applicability, the transferability,
and the generalizability of the findings to the specific
disadvantaged populations of interest (recognizing it is
impossible to make these judgments for all possible pop-
ulations). Authors should clearly report any disadvan-
taged population that was specified in the protocol and
the reasons that consideration was given to the applic-
ability of the results to the specified population. The ap-
plicability of the findings of a review to disadvantaged
populations should be addressed similarly to consider-
ations of applicability to any other population [8, 64, 90,
99, 100].
Authors should specify disadvantaged populations or
settings for which the intervention is likely to be rele-
vant. In the discussion review authors should consider
the potential impact of: economic status, employment or
occupation, education, place of residence, gender, and
ethnicity as potential influences on the applicability of
the results to disadvantaged populations, as well as re-
source or capacity constraints, health system arrange-
ments or baseline conditions as potential reasons for
there being a difference in the potential applicability of
the results to low-income countries or disadvantaged
populations. Authors should justify any judgments about
applicability using transparent methods. There is no
agreed checklist for judging applicability, though many
are available [81, 101]. However, authors should provide
rationale, and any data used to make judgements about
applicability.
Applicability of results is often overlooked in system-
atic reviews. For example, an assessment of systematic
reviews related to public health found that only 13 %
discussed applicability [102]. The panel felt that the con-
clusion of an equity-focused systematic review should
provide a transparent assessment of the applicability, the
transferability, and the generalizability of the findings to
at least one specific disadvantaged population of interest.
This population should be pre-specified in the protocol
with rationale. Authors should also specify additional
disadvantaged populations or settings for which the
intervention is likely to be relevant.
The applicability of the findings of a review to disad-
vantaged populations should be addressed similarly to
considerations of applicability to any other population,
using explicit methods [8, 64, 90, 99, 100]. There is no
agreed checklist for judging applicability, though many
checklists are available [81]. Authors should provide a
rationale for the method they choose, and any data used
to make judgements about applicability, such as other
evidence about the possible impact of economic status,
employment or occupation, education, place of residence,
gender, and ethnicity, as well as resource or capacity con-
straints, health system arrangements or baseline conditions.
Item 26A: in addition, for equity-focused systematic re-
views: Provide implications for research, practice, or pol-
icy related to equity where relevant (e.g., types of research
needed to address unanswered questions).
Examples
○ “The body of evidence in this review provides some
support for the hypothesis that obesity prevention
Table 4 Example of a separate summary of findings table because of expected differences for disadvantaged population
Positive Neutral Negative Mixed Unclear Total
Increases in price/tax of tobacco products 14 6 4 1 2 27
Smokefree-voluntary, regional, partial 1 1 19 0 4 25
Smokefree-compulsory, national, comprehensive 2 9 6 1 4 19
Mass media campaigns 3 2 5 2 6 18
Mass media campaigns-quitlines and NRT 5 3 3 0 1 12
Controls on advertising, promotion and marketing of tobacco 2 7 0 0 9
Population-level cessation support interventions 4 2 0 1 2 9
Setting based interventions(community, workplace, hospital) 2 4 1 0 0 7
Multiple policies 0 2 0 1 1 4
Total policies 33 36 38 6 17 130a
Total studies 31b 30 37 6 14b 117
Summary equity impact of included studies and policies
aEight studies assessed more than one type of pilocy Dinno 200935 = Smokefree, Price/Tax; Frieden 200549 = Smoke, Price/Tax, Multiple policies; Hawk 99 = Mass
Media, Mass Media-quitlines and NRT; Hawkins 2012 53 = Smokefree, Price/Tax
bLevy 200641 = Smokefree, Price/Tax, Mass Media; Nagelhout 201354 = Smokefree, Price/Tax Media; Scaap 200847 = Smokefree, Price/Tax, Controls on advertising,
promotion and marketing of tobacco, Multiple policies; Wilson 2010a115 = Controls on advertising, promotion and marketing of tobacco, Mass media-quitlines
and NRT
[95]
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interventions in children can be effective, and where
examined, have not caused adverse outcomes or
increased health inequalities. To this end, the direction
of research and evaluation must move into how to
implement effectively to scale, sustain the impacts over
time and ensure equitable outcomes. In addition,
interventions need to be developed that can be
embedded into ongoing practice and operating systems,
rather than implementing interventions that are
resource intensive and cannot be maintained long-
term.” [20]
○ “Future research should promote the development
of effective interventions to enhance the online health
literacy of consumers. Thus there is a need for well-
designed and rigorously conducted randomised
controlled trials (RCTs). These RCTs should involve
diverse participants (regarding disease status, age,
socio-economic group and gender) to analyse to what
extent online health literacy reduces a barrier to using
the internet for health information, or if socio-economic
group, gender and age are more important in influencing
internet use (Livingstone 2006). Trials should be
conducted in different settings (including low, middle and
high income countries) and should examine interventions
to enhance consumers online health literacy (search,
appraisal and use of online health information) like
internet training courses.” [103]
Explanation - Implications for research, practice, and
policy should highlight the effects on equity. This sec-
tions of the review should state the research that needs
to be done to address existing knowledge gaps and
should also suggest what the unanswered research ques-
tions are – that is, by specifying the questions that still
need answering instead of stating that we “need more
research”.
Discussion
We developed the PRISMA-E 2012 checklist following
guidance suggested by Moher and colleagues [23]. This
reporting guideline is intended to improve transparency
and completeness of reporting of equity-focused system-
atic reviews. Improved reporting can lead to better judge-
ment of applicability by policy makers which may result in
more appropriate policies and programs and may lead to
reductions in health inequities.
This explanation and elaboration document is intended
to accompany the PRISMA-E 2012 Statement to improve
understanding of the reporting guideline for users [15].
The original PRISMA Statement has been endorsed by
almost 200 journals; therefore, we recommend that au-
thors of equity-focused systematic reviews use both the
PRISMA checklist and the PRISMA-E 2012 checklist.
Potential limitations of the PRISMA-E 2012 checklist
are that certain terminology used in the reporting guide-
line may not be well defined or widely used and may be
defined differently by different users. To mitigate these
concerns, we pilot tested the checklist with different
groups of systematic reviews authors including those in
high-income as well as low- and middle-income coun-
tries. The results of these pilot tests have been reported
elsewhere [104]. While some of the PRISMA-E 2012 ex-
tension items may apply to non-equity-focused reviews,
we felt that their importance for equity-focused reviews
was great enough to warrant development of a specific
reporting guideline for these reviews. In addition, there
is no planned update of the PRISMA Statement so we
have included them in this reporting guideline.
We are committed to a broad based dissemination
strategy of PRISMA-E 2012 and hope to have endorse-
ment by all journals endorsing the PRISMA Statement.
Our dissemination strategy includes contact with journal
editors, systematic review authors and trainers, and dis-
semination at meetings and conferences. We will con-
tinue to monitor endorsement of the checklist by
journal editors. We plan to evaluate this reporting guide-
line at a future date to determine its impact on reporting
of equity-focused systematic reviews. We will measure
the ‘footprint’ of PRISMA-E 2012 by tracking the num-
ber of requests for support (e.g., emails, phone calls),
and indicators of sharing of PRISMA-E 2012 through
various networks, such as LinkedIn, Twitter, and Face-
book. We will also measure web metrics, such as down-
loads of the Word file of the reporting guideline
checklist from our website.
We hope that journal endorsement and implementa-
tion, and use by systematic reviewers will improve the
reporting of equity-focused systematic reviews. Wide-
spread use of the PRISMA-E 2012 checklist may in-
crease the requests for more data from primary
researchers which may in turn improve the reporting of
equity considerations in primary research.
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